The HemOnc Pulse cover image

What Is the Cost-Effectiveness of Pola-R-CHP in DLBCL?

The HemOnc Pulse

00:00

The Cost Effectiveness of a Novel Therapy for Lymphoma

Dr. Nikhil Firovengadam is a gastroenterologist and therapeutic endoscopist who primarily focuses clinically on pancreatic laryoninoscopy. Dr. Swehta works as an assistant professor at City of Hope in the lymphoma division. The project was to model a regimen that was novel and potentially would change the primary regimen used to treat DLBCL.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app